What’s Going On Here? Global healthcare and consumer products giant Johnson & Johnson (J&J) Suda-fed investors with fourth-quarter sales that fell short of expectations. What Does This Mean? J&J’s global sales across 2019 ended essentially flat on the year before. While pharmaceuticals revenue climbed almost 4%, this was largely offset by a similar decline in medical device…